首页|期刊导航|Guideline and Standard in Chinese Medicine|Interpretation and reflections on technical specifications for dispensing commonly used Chinese patent medicines in clinical emergency and critical care,part 10,pill(T/CACM 1378.10–2022)

Interpretation and reflections on technical specifications for dispensing commonly used Chinese patent medicines in clinical emergency and critical care,part 10,pill(T/CACM 1378.10–2022)OA

中文摘要

The standard“Technical Specifications for Dispensing Commonly Used Chinese Patent Medicines in Clinical Emergency and Critical Care-Part 10:Pills”(T/CACM 1378.10)was approved and released by the China Association of Chinese Medicine on January 11,2022.The formulation of this standard fills the gap in the standardization of dispensing processes in the application of Chinese patent medicines in pill form in emergency and critical care settings,providing pharmacists with a scientific and systematic operational guide.Through literature research,questionnaire surveys,and expert verification,the standard establishes dispensing technical specifications for 9 core technical procedures:purchase and acceptance inspection,inventory management,prescription review,prescription dispensing,prescription verification,drug distribution and medication instruction,medication monitoring,prescription evaluation,and pharmacovigilance.Specific recommendations for medication monitoring,prescription review,and drug distribution instruction are also provided for representative medications such as Huafeng pills,Angong Niuhuang pills,and Suxiao Jiuxin pills.This standard emphasizes a scientific and practical dispensing process and puts forward special requirements for the whole chain management of dispensing Chinese patent medicines,contributing to the enhanced safety and efficacy of clinical medication.This article interprets the standard Technical Specification for Dispensing of Chinese Patent Medicine in Clinical Acute or Critical Diseases Part10:Pills,proposes 20 related suggestions,and demonstrates the rigorous process and core contents of standard formulation,providing a direction for future research and practice.

Siyu Tao;Jiaxin Tian;Fangyuan Mu;Xiaolong Guo;Peihong Li

Department of Pharmacy,Xiongan Xuanwu Hospital,Xiongan New Area,China Department of Pharmacy,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing,ChinaDepartment of Asset Management,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing,ChinaDepartment of Pharmacy,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing,ChinaDepartment of Pharmacy,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing,ChinaDepartment of Pharmacy,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing,China

医药卫生

emergency and critical carepill chinese patent medicinesdispensingstandardrational drug use

《Guideline and Standard in Chinese Medicine》 2026 (2)

P.157-168,12

supported by the National Key Research and Development Program Project(2019YFC1712002)the National Natural Science Foundation of China(82374055).

10.1097/gscm.0000000000000107

评论